Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 38 of 59, showing 10 Applications out of 584 total, starting on record 371, ending on 380

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

371.

ECCT/19/08/02   LOxaF- N Trial
    LOW DOSE OXYTOCIN AS AN ADJUNCT TO FOLEY CATHETER FOR CERVICAL RIPENING IN NULLIPAROUS WOMEN AT MTRH, ELDORET, KENYA: A RANDOMISED CONTROLLED TRIAL.   
Principal Investigator(s)
1. Patrick Omondi Otieno
Site(s) in Kenya
The Riley Mother and Baby Hospital (RMBH) at Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya.
 
01-10-2019 View

372.

ECCT/19/08/01   Use of malaria infection by injection to study malaria transmission
    Safety and feasibility of a malaria transmission model in semi-immune Kenyan adults using Plasmodium falciparum sporozoites   
Principal Investigator(s)
1. Melissa Kapulu
2. Philip Bejon
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
 
15-11-2019 View

373.

ECCT/19/07/01   IMPROVE-2
      chemoprevention with monthly IPTp with dihydroartemisinin-piperaquine for malaria in HIV-infected pregnant participants on daily cotrimoxazole in Kenya and Malawi: a multi-centre placebo-controlled trial(IMPROVE-2).    
Principal Investigator(s)
1. Hellen Cherono Barsosio
2. Simon Kariuki
Site(s) in Kenya
1. Ahero Sub-County Hospital (Kisumu county)
2. Rabuor Sub-County Hospital (Kisumu county)
3. Akala Sub-County Hospital (Siaya county)
 
03-10-2019 View

374.

ECCT/19/06/03   Evaluation of the RTS,S vaccine implementation in Kenya (MVPE)
      An evaluation of the cluster-randomised pilot implementation of the RTS,S/AS01 malaria vaccine through routine health systems in western Kenya         
Principal Investigator(s)
1. Aaron Samuels Samuels
Site(s) in Kenya
1. Bungoma County (Bung\'oma county)
2. Busia County (Busia county)
3. Homa Bay (Homa Bay county)
4. Kakamega County (Kakamega county)
5. Kisumu County (Kisumu county)
6. Migori County (Migori county)
7. Siaya County (Siaya county)
8. Vihiga County (Vihiga county)
 
13-08-2019 View

375.

ECCT/19/06/02   The A-PLUS study
    Prevention of Maternal and Neonatal Death/Infections with a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-Income Countries): a Randomized Controlled Trial   
Principal Investigator(s)
1. Prof Fabian Esamai Omoding Esamai
Site(s) in Kenya
1. Alupe, Sirisia, Bokoli (Bung\'oma county)
2. Nambale, Nasewa, Lukolis, Khunyangu (Busia county)
3. Mumias (Kakamega county)
 
09-06-2020 View

376.

ECCT/19/06/01   EPI 003
    A prospective study to evaluate the safety, effectiveness and impact of the RTS,S/AS01E vaccine in young children in sub-Saharan Africa.   
Principal Investigator(s)
1. Walter Otieno
Site(s) in Kenya
1. Ahero clinical triasl unit (Kisumu county)
2. KEMI CDC (Siaya county)
 
17-06-2019 View

377.

ECCT/19/05/03   SEARCH
    Supportive Care and Antibiotics for Severe Pneumonia among Hospitalised Children    
Principal Investigator(s)
1. Ambrose Agweyu
Site(s) in Kenya
1. Mama Lucy Kibaki Hospital (Nairobi City county)
2. Kiambu County Referral Hospital (Kiambu county)
3. Machakos County Referral Hospital (Machakos county)
4. Embu County Referral Hospital (Embu county)
5. Naivasha County Hospital (Nakuru county)
6. Bungoma County Referral Hospital (Bung\'oma county)
7. Busia County Referral Hospital (Busia county)
8. Kitale County Referral Hospital (Trans Nzoia county)
9. Kisumu East Hospital (Kisumu county)
10. Kakamega County Referral Hospital, Kenya (Kakamega county)
 
21-07-2019 View

378.

ECCT/19/05/02   ETNA
    EVALUATION OF TECHNOLOGIES FOR NEONATES IN AFRICA   
Principal Investigator(s)
1. PROF WILLIAM MAINA MACHARIA
Site(s) in Kenya
1. AGA KHAN UNIVERSITY HOSPITAL (Nairobi City county)
2. PUMWANI MATERNITY HOSPITAL (Nairobi City county)
 
18-06-2019 View

379.

ECCT/19/05/01   A randomized, double-blinded, placebo-controlled, dose-escalation phase 1 clinical trial to evaluate the safety and immunogenicity of recombinant HIV envelope protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in healthy, HIV--1 uninfected adults
    A randomized, double-blinded, placebo-controlled, dose-escalation phase 1 clinical trial to evaluate the safety and immunogenicity of recombinant HIV envelope protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in healthy, HIV--1 uninfected adults   
Principal Investigator(s)
1. Omu Anzala
Site(s) in Kenya
KAVI-ICR KNH SITE
 
08-07-2019 View

380.

ECCT/19/04/05   PHOENIx MDR-TB
    A5300B/I2003B/PHOENIx "Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients"   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
30-09-2019 View